Brief: Ono Enters Into A Drug Discovery Collaboration Agreement With Adimab

ONO PHARMACEUTICAL

27/09/2023 11:11

Sept 27 (Reuters) - Ono Pharmaceutical Co Ltd  4528.T :
    * ONO ENTERS INTO A DRUG DISCOVERY COLLABORATION AGREEMENT
WITH
ADIMAB TO DISCOVER NOVEL ANTIBODY DRUGS IN THE ONCOLOGY FIELD
    * ONO PHARMACEUTICAL CO LTD - UNDER TERMS OF AGREEMENT,
ADIMAB
WILL DISCOVER NOVEL THERAPEUTIC ANTIBODIES AGAINST MULTIPLE
TARGETS SELECTED BY ONO
    * ONO PHARMACEUTICAL - TO PAY TO ADIMAB UP-FRONT PAYMENT,
RESEARCH
AND DEVELOPMENT FUNDING, SUCCESS-BASED MILESTONE ON RESEARCH,
CLINICAL DEVELOPMENT, REGULATORY PROGRESS

Source text for Eikon:  ID:nPn9BQQjya 
Further company coverage:  4528.T 

 ((Reuters.Briefs@thomsonreuters.com;))